Agency Forms Undergoing Paperwork Reduction Act Review, 12347-12348 [2024-03241]
Download as PDF
12347
Federal Register / Vol. 89, No. 33 / Friday, February 16, 2024 / Notices
to and utilization of HIV-related medical
care and services, the quality of HIVrelated ambulatory care, and HIVrelated behaviors and clinical outcomes.
For the proposed project, the same
data collection methods will be used as
for the currently approved project. Data
would be collected from a probability
sample of HIV-diagnosed adults in the
U.S. who consent to an interview and
abstraction of their medical records. As
for the currently approved project, deidentified information would also be
extracted from HIV case surveillance
records for a dataset (referred to as the
minimum dataset), which is used to
assess non-response bias, for quality
control, to improve the ability of MMP
to monitor ongoing care and treatment
of HIV-infected persons, and to make
inferences from the MMP sample to
HIV-diagnosed persons nationally. No
other Federal agency collects such
nationally representative populationbased information from HIV-diagnosed
adults. The data are expected to have
significant implications for policy,
program development, and resource
allocation at the State/local and national
levels.
The changes proposed in this
Revision request update the data
collection system to meet prevailing
information needs and enhance the
value of MMP data, while remaining
within the scope of the currently
approved project purpose. The burden
is the same as in the currently approved
project. Changes were made that did not
affect the burden are listed below:
• Revisions to the Interview
Questionnaire were made to improve
coherence, boost the efficiency of the
data collection, and increase the
relevance and value of the information.
These changes did not affect the average
burden per response.
• Revisions to the Medical Record
Abstraction Data Elements were made to
streamline the information collected
and add important questions, such as
those related to mpox vaccination.
Because the medical records are
abstracted by MMP staff, these changes
do not affect the burden of the project.
• The Interview and Medical Record
data collection system were integrated
to improve project efficiency and
enhance data quality.
This proposed data collection would
supplement the National HIV
Surveillance System (NHSS, OMB
Control No. 0920–0573, Exp. 02/28/
2026) in 23 selected State and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
infection and AIDS. Through their
participation, respondents will help to
improve programs to prevent HIV
infection as well as services for those
who already have HIV. Participation of
respondents is voluntary. Total
estimated annual burden requested is
5,707 hours. There is no cost to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State and Local Health Departments ............
Interview Questionnaire ................................
Look up contact information ..........................
Approach persons for enrollment ..................
Pull medical records ......................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–03240 Filed 2–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–1186]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Information
Collection for Tuberculosis Data from
Referring Entities to CureTB’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
VerDate Sep<11>2014
17:24 Feb 15, 2024
Jkt 262001
notice on December 15, 2023 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
7,760
1,940
970
7,760
Number of
responses per
respondent
Average hours
per response
1
1
1
1
40/60
2/60
5/60
3/60
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Information Collection for
Tuberculosis Data from Referring
E:\FR\FM\16FEN1.SGM
16FEN1
12348
Federal Register / Vol. 89, No. 33 / Friday, February 16, 2024 / Notices
Entities to CureTB (OMB Control No.
0920–1186, Exp. 02/29/2024)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The CureTB program works to prevent
the spread of tuberculosis (TB) among
people who cross international borders.
To reduce disease transmission and the
emergence of drug-resistant TB, CureTB
connects people with TB to healthcare
services as they move between the
United States and other countries. The
program is a collaboration between
CDC’s Division of Global Migration
Health (DGMH) and the County of San
Diego’s Tuberculosis Control Program.
CureTB collaborates with health
authorities throughout the United States
and around the world to link people
with TB to care at their destinations.
Health departments, healthcare
providers, and others seeking help in
linking patients to ongoing TB care in
other countries can refer patients to
CureTB.
Information will be collected from the
referring entities, which are State and
local health departments and Federal
immigration and detention agencies.
Whenever the referring entities provide
clinical services to an individual with
TB who has imminent plans to relocate,
and an individual needs continuity of
care in their new location, CDC CureTB
is contacted to assist with coordinating
that care. TB patients may also be a
respondent if critical clinical or contact
data is missing and requires follow-up
by CureTB to complete a patient’s
referral information set. The request for
CDC CureTB services comes from the
referring entities and they supply the
information at the time the patient is
likely to leave their jurisdiction. The
referring entities update information
only if relevant information to the
patient’s care becomes available to them
after their first communication with
CDC CureTB. Therefore, information is
already largely collected by CDC
CureTB only at one point in time, with
subsequent information only collected if
departure is delayed or when initially
pending information becomes available
and this is beyond the control of CDC.
Post relocation of the TB patient, data
is also collected from the receiving
physicians to determine patient
outcomes. CDC CureTB contacts the
physician an average of every two
months during the standard six-month
TB treatment process. The data provides
valuable information on globally mobile
populations and allows CDC to assist in
continuity of TB care and monitor the
effectiveness of the program.
The continuous expansion and use of
the CureTB Program requires certain
processes be evaluated. The
Supplemental CureTB Program Partner
Satisfaction Assessment Questionnaire
will guide CureTB in making
appropriate program improvements to
best serve referring partners. The
Questionnaires will not be used to
collect demographic or clinical
information, rather, they will ask the
referring partners about their experience
separately from the other forms already
used for demographic and clinical
information for each patient.
As part of this revision request,
CureTB is updating the number of
respondents and total burden hours.
There are no changes to the data
collection instruments. CDC requests
OMB approval for an estimated 1,139
annual burden hours. There are no costs
to respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Form name
U.S. Health Departments ..................................
TB patients referred by U.S. health departments.
TB patients referred by ICE ..............................
TB treating physicians in new country .............
CureTB Transnational Notification ...................
CureTB Transnational Notification ...................
100
200
3
1
30/60
5/60
CureTB Transnational Notification ...................
CureTB Telephone Script Clinician/foreign
health authority Referral Follow-up.
CureTB Contact/Source Investigation (CI/SI)
Notification.
CureTB Partner Feedback (Satisfaction Assessment)—Questionnaire 1.
CureTB Partner Feedback (Satisfaction Assessment)—Questionnaire 2.
600
900
1
3
45/60
10/60
20
5
30/60
100
1
10/60
50
1
6/60
U.S. Health Departments ..................................
U.S. Health Department (Local & State) ..........
U.S. Health Department ...................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–03241 Filed 2–15–24; 8:45 am]
[30Day–24–0138]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Pulmonary
Function Testing Course Approval
Program’’ to the Office of Management
VerDate Sep<11>2014
17:24 Feb 15, 2024
Jkt 262001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on October
30, 2023 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
E:\FR\FM\16FEN1.SGM
16FEN1
Agencies
[Federal Register Volume 89, Number 33 (Friday, February 16, 2024)]
[Notices]
[Pages 12347-12348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-1186]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Information Collection for Tuberculosis
Data from Referring Entities to CureTB'' to the Office of Management
and Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on December 15, 2023 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Information Collection for Tuberculosis Data from Referring
[[Page 12348]]
Entities to CureTB (OMB Control No. 0920-1186, Exp. 02/29/2024)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The CureTB program works to prevent the spread of tuberculosis (TB)
among people who cross international borders. To reduce disease
transmission and the emergence of drug-resistant TB, CureTB connects
people with TB to healthcare services as they move between the United
States and other countries. The program is a collaboration between
CDC's Division of Global Migration Health (DGMH) and the County of San
Diego's Tuberculosis Control Program. CureTB collaborates with health
authorities throughout the United States and around the world to link
people with TB to care at their destinations. Health departments,
healthcare providers, and others seeking help in linking patients to
ongoing TB care in other countries can refer patients to CureTB.
Information will be collected from the referring entities, which
are State and local health departments and Federal immigration and
detention agencies. Whenever the referring entities provide clinical
services to an individual with TB who has imminent plans to relocate,
and an individual needs continuity of care in their new location, CDC
CureTB is contacted to assist with coordinating that care. TB patients
may also be a respondent if critical clinical or contact data is
missing and requires follow-up by CureTB to complete a patient's
referral information set. The request for CDC CureTB services comes
from the referring entities and they supply the information at the time
the patient is likely to leave their jurisdiction. The referring
entities update information only if relevant information to the
patient's care becomes available to them after their first
communication with CDC CureTB. Therefore, information is already
largely collected by CDC CureTB only at one point in time, with
subsequent information only collected if departure is delayed or when
initially pending information becomes available and this is beyond the
control of CDC.
Post relocation of the TB patient, data is also collected from the
receiving physicians to determine patient outcomes. CDC CureTB contacts
the physician an average of every two months during the standard six-
month TB treatment process. The data provides valuable information on
globally mobile populations and allows CDC to assist in continuity of
TB care and monitor the effectiveness of the program.
The continuous expansion and use of the CureTB Program requires
certain processes be evaluated. The Supplemental CureTB Program Partner
Satisfaction Assessment Questionnaire will guide CureTB in making
appropriate program improvements to best serve referring partners. The
Questionnaires will not be used to collect demographic or clinical
information, rather, they will ask the referring partners about their
experience separately from the other forms already used for demographic
and clinical information for each patient.
As part of this revision request, CureTB is updating the number of
respondents and total burden hours. There are no changes to the data
collection instruments. CDC requests OMB approval for an estimated
1,139 annual burden hours. There are no costs to respondents other than
their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response
respondent (in hours)
----------------------------------------------------------------------------------------------------------------
U.S. Health Departments................ CureTB Transnational 100 3 30/60
Notification.
TB patients referred by U.S. health CureTB Transnational 200 1 5/60
departments. Notification.
TB patients referred by ICE............ CureTB Transnational 600 1 45/60
Notification.
TB treating physicians in new country.. CureTB Telephone Script 900 3 10/60
Clinician/foreign health
authority Referral Follow-
up.
U.S. Health Departments................ CureTB Contact/Source 20 5 30/60
Investigation (CI/SI)
Notification.
U.S. Health Department (Local & State). CureTB Partner Feedback 100 1 10/60
(Satisfaction
Assessment)--Questionnair
e 1.
U.S. Health Department................. CureTB Partner Feedback 50 1 6/60
(Satisfaction
Assessment)--Questionnair
e 2.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-03241 Filed 2-15-24; 8:45 am]
BILLING CODE 4163-18-P